Clinical trial
Randomized Clinical Trial to Assess the Effectiveness of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 1 (TNT-1 Study)
NCT02624063 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Trial to Assess the Effectiveness of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 1 (TNT-1 Study)
- Lead sponsor
- Federal University of São Paulo
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- May 31, 2017
- Enrollment
- 121 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.